Thursday, October 22, 2026

Remembering the Cheonan Incident: 16 Years of Sacrifice and Truth Amidst North Korean Denial

Students honor 55 heroes of the West Sea Defense as the People Power Party commemorates the Cheonan sinking's anniversary and condemns distortion.

North Korea Decries U.S.-ROK Drills as ‘Malicious War Rehearsals’ After Pocheon Mishap

North Korea exploits a fighter jet mishap in Pocheon to criticize U.S.-ROK military drills, warning of potential conflict escalation.

North Korea Shows Off Missile Factory—and Its Workers’ Faces for the First Time

Kim Jong Un inspects a military factory, revealing personnel faces, indicating confidence in arms production and ties with Russia.

Jeong Eun Kim

Author's Latest

AITRICS Showcases Clinical Value and Real-World Applications of AITRICS-VC (VitalCare) Solution

AITRICS showcased its VitalCare AI solution for predicting critical health conditions at a symposium, enhancing clinical decision-making.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

PharmGen Science Releases Tabapheno Extended-Release for Dyslipidemia Treatment

PharmGen Science launches Tabapheno Extended-Release Tablets for mixed dyslipidemia, enhancing treatment convenience and adherence.

MSD Korea Announced at Bio Korea 2026 that Korea is a Crucial Hub for Global Innovation

Korea is now a key innovation hub for MSD, focusing on neuroscience and clinical research collaborations, with significant R&D investments.

Korea’s Biotech Healthcare Firms Possess Cutting-edge AI Diagnostics and Precision Medicine

South Korea's biotech sector excels in technology but needs better storytelling and governance to attract global investments.

Celltrion Launches New Autoimmune Drug Avtozma in Japan

Celltrion launches Avtozma for autoimmune diseases in Japan, expanding its product portfolio and strengthening market presence.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

South Korea Surpasses 2 Million Medical Tourists in 2025, with Double Visa-Free Chinese Visitors

South Korea welcomed over 2 million foreign patients in 2025, driven by a visa-free policy for Chinese tourists and high demand for medical services.

HK inno.N partners with Atomatrix to co-develop AI-based next-generation obesity drug

HK inno.N partners with Atomatrix to develop AI-driven obesity treatments, focusing on novel small-molecule candidates.

Merz named among ‘Global Sustainable Brands & Leaders 100’ for second consecutive year

Merz Aesthetics Asia recognized for sustainability efforts, CEO Yoo Soo-yeon named Global Sustainable Innovation Leader for second year.

Waycen’s AI Endoscopy to Transform Vietnam’s Healthcare Landscape

Waycen joins Vietnam's economic delegation to expand its AI medtech business, enhancing partnerships and market presence in healthcare.

How Hippocrat Labs Achieved 4 ISO Certifications: A Game Changer for Digital Healthcare in 2026

Hippocrat Labs secures four ISO certifications for information security, enhancing healthcare data protection amid rising cyber threats.

Moderna secures EU approval for combined influenza-COVID vaccine mCOMIRNATY

Moderna's mCOMIRNATY, a combined COVID-19 and influenza vaccine, gains European approval for adults 50+, enhancing its respiratory portfolio.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.